SPARKS, Md., July 6, 2011 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today that Patrick R. Murray, Ph.D. joined the Company as Worldwide Director, Scientific Affairs, Diagnostic Systems.
Dr. Murray brings experience from an esteemed career in academics and clinical practice, most recently serving as Chief of the Microbiology Service and Senior Scientist at the National Institutes of Health (NIH) Clinical Center.
BD Diagnostics has a rich history of providing first-to-market diagnostic solutions and is currently focused on identifying and developing innovative technologies in Infectious Disease, Women's Health and Cancer Diagnostics.
In his new role, Dr. Murray will leverage his clinical expertise to best define new product requirements, evaluate new technologies and engage external experts and institutions in BD's innovation process. He will be based in the Company's Sparks, MD office.
"We are very pleased to have a leading expert in infectious disease diagnostics, such as Dr. Murray joining our team," said Tom Polen, President of BD Diagnostics - Diagnostic Systems. "His clinical perspective will be a great addition to BD as we continue to pursue new breakthrough diagnostic solutions."
While at NIH, Dr. Murray oversaw the clinical and research programs in Microbiology as well as postdoctoral training of Ph.D. and M.D. microbiology and infectious disease fellows. He received the NIH Clinical Center Director's Award for Patient Care and the NIH Director's Award for Clinical Research. Prior to NIH, Dr. Murray served as a Professor and Head of Clinical Microbiology at the University of Maryland Medical Center and as Professor in the Department of Medicine & Pathology at Washington University in Saint Louis. He received his Ph.D. degree in Microbiology at UCLA and conducted postgraduate training in Clinical Microbiology at the Mayo Clinic in Rochester, MN.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
|SOURCE BD-Becton Dickinson|
Copyright©2010 PR Newswire.
All rights reserved